Paying user area
Try for free
HCA Healthcare Inc. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to HCA Healthcare Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
The financial data for HCA Healthcare Inc. over the five-year period ending December 31, 2021, reveals notable trends in both reported and adjusted net income attributable to the company.
- Reported Net Income
- The reported net income displays a general upward trend throughout the period. Starting at 2,216 million US dollars in 2017, it increased substantially to 3,787 million US dollars in 2018, reflecting strong growth. A slight decrease to 3,505 million US dollars occurred in 2019, followed by a modest rebound to 3,754 million US dollars in 2020. The most significant increase is observed in 2021, where reported net income nearly doubled the prior year’s figure, reaching 6,956 million US dollars.
- Adjusted Net Income
- The adjusted net income follows a similar pattern to reported net income, with figures closely aligned each year. It starts at 2,216 million US dollars in 2017, marginally diverging from reported figures in subsequent years but generally staying within a close range. Adjusted net income increases markedly to 3,782 million US dollars in 2018, then slightly rises to 3,516 million US dollars in 2019. In 2020, it continues its upward movement to 3,765 million US dollars. The peak in 2021 is again significant, with adjusted net income reaching 6,943 million US dollars. This pattern suggests that adjustments to net income have minimal effect on the overall trend, confirming the robustness of underlying earnings growth.
Overall, the data suggests sustained profitability with accelerated income growth in the latter part of the analysis period, particularly in 2021. The close alignment between reported and adjusted net income indicates consistent financial reporting with limited distortions from exceptional or non-recurring items.
Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
The financial data reveals evolving profitability and return metrics over the five-year span under review.
- Net Profit Margin
- The reported net profit margin exhibited an upward trajectory, beginning at 5.08% in 2017 and increasing moderately to 8.11% in 2018. It then declined slightly in 2019 to 6.83% before recovering to 7.28% in 2020 and significantly rising to 11.84% in 2021. This pattern indicates a general improvement in profitability efficiency over the period, with a notable acceleration in the last year. The adjusted net profit margin closely mirrors the reported figures, confirming the consistency and reliability of profitability after removing exceptional items or one-time adjustments.
- Return on Equity (ROE)
- Data on reported and adjusted ROE is absent for the years 2017 through 2021, except for a single extraordinarily high value reported in the unspecified year, recorded as 656.29% (reported) and 658.22% (adjusted). Such extreme figures likely reflect an anomaly, accounting method change, or reporting error in the return on shareholders’ equity and cannot be interpreted as typical performance metrics.
- Return on Assets (ROA)
- The reported ROA follows a pattern somewhat similar to the net profit margin, starting at 6.06% in 2017 and increasing to a peak of 9.66% in 2018. This was followed by a decline to 7.78% in 2019 and a slight recovery to 7.9% in 2020. The metric then improved significantly to 13.71% in 2021. The adjusted ROA figures track closely with the reported data, supporting the validity of the observed trends. This overall improvement in asset utilization efficiency suggests enhanced operational performance, especially in the latter stages of the period analyzed.
HCA Healthcare Inc., Profitability Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
2021 Calculations
1 Net profit margin = 100 × Net income attributable to HCA Healthcare, Inc. ÷ Revenues
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net income attributable to HCA Healthcare, Inc. ÷ Revenues
= 100 × ÷ =
- Net Income Trend
- The reported net income attributable to the company shows a notable increase over the five-year period. Starting at $2,216 million in 2017, the income rose to $3,787 million in 2018, marking a significant growth. It slightly declined to $3,505 million in 2019 but rebounded to $3,754 million in 2020. The most marked increase occurred in 2021, with net income nearly doubling from the previous year to reach $6,956 million.
- Adjusted Net Income Trend
- The adjusted net income follows a similar trajectory to the reported net income, indicating that adjustments made for the reported figures have a minimal impact on the overall trend. The figures start at $2,216 million in 2017 and progress to $3,782 million in 2018. Slight fluctuations continue over the subsequent years, with $3,516 million in 2019 and $3,765 million in 2020. In 2021, the adjusted net income also experiences a substantial increase, reaching $6,943 million, comparable to the reported figure.
- Net Profit Margin Analysis
- The reported net profit margin shows improvement from 5.08% in 2017 to 8.11% in 2018, indicating increased profitability relative to revenue. However, it decreased slightly to 6.83% in 2019 before recovering to 7.28% in 2020. The profit margin sees a significant rise in 2021, achieving 11.84%, reflecting enhanced operational efficiency or pricing power.
- Adjusted Net Profit Margin Analysis
- Trends in the adjusted net profit margin align closely with the reported margins, suggesting limited impact from adjustment factors on profitability ratios. The margin increased from 5.08% in 2017 to 8.1% in 2018, dipped slightly to 6.85% in 2019, rose to 7.31% in 2020, and then experienced a sharp increase to 11.82% in 2021.
- Overall Insights
- The data indicates a positive financial performance trend for the company, with both reported and adjusted net incomes growing significantly over the period. The net profit margins exhibit a similar pattern, with margins generally improving year over year and peaking substantially in 2021. The consistency between reported and adjusted figures suggests that income adjustments have minimal effect on the company’s profitability trends. The exceptional growth in 2021 could be indicative of strong operational improvements, favorable market conditions, or strategic initiatives contributing to profitability enhancement.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
2021 Calculations
1 ROE = 100 × Net income attributable to HCA Healthcare, Inc. ÷ Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc.
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net income attributable to HCA Healthcare, Inc. ÷ Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc.
= 100 × ÷ =
The financial data shows a positive trend in both reported and adjusted net income attributable to the company over the five-year period from 2017 to 2021.
- Net Income
- The reported net income increased significantly from $2,216 million in 2017 to $6,956 million in 2021. This growth suggests improved profitability over time. The adjusted net income figures follow a similar pattern, rising from $2,216 million in 2017 to $6,943 million in 2021, indicating that adjustments made to the reported income do not materially affect the overall upward trend.
- Return on Equity (ROE)
- The ROE data is incomplete for most years, with values only reported for 2020. The reported ROE in 2020 stands exceptionally high at 656.29%, and similarly, the adjusted ROE is 658.22%. These unusually elevated ROE values may indicate one-off events, accounting adjustments, or low equity base during that year, which should be analyzed further to understand the underlying causes. Without comparable data for other years, it is difficult to assess trends or consistency in the company's equity efficiency.
Overall, the company's net income has demonstrated a strong upward trajectory, reflecting enhanced earnings capacity. However, the ROE data limitations restrict the ability to draw conclusions about returns on shareholders' equity across the period. Further analysis with more complete equity information would be necessary to fully evaluate financial performance from an equity perspective.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
2021 Calculations
1 ROA = 100 × Net income attributable to HCA Healthcare, Inc. ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net income attributable to HCA Healthcare, Inc. ÷ Total assets
= 100 × ÷ =
The financial data reflects a generally positive performance trend over the five-year period.
- Net Income
- Both reported and adjusted net income attributable to the company show substantial growth from 2017 to 2021. Reported net income increased from $2,216 million in 2017 to $6,956 million in 2021. Adjusted net income parallels this rise closely, moving from $2,216 million to $6,943 million over the same period. The values for reported and adjusted net income remain very close throughout the years, indicating minimal adjustments impacting the net income figures.
- Return on Assets (ROA)
- The reported ROA had an upward trend as well, increasing from 6.06% in 2017 to 13.71% in 2021. Adjusted ROA closely aligns with the reported figures, starting at 6.06% and rising to 13.68%, showing a consistent improvement in asset efficiency. The ROA slightly dipped from 2018 to 2019 before continuing its ascent towards 2021, suggesting some short-term variations but an overall positive trajectory.
- Comparative Observations
- The alignment between reported and adjusted figures throughout the years indicates that adjustments have had little impact on the core earnings and efficiency metrics. The consistent increase in net income and ROA reflects operational improvements and enhanced profitability. The most significant jump occurs between 2020 and 2021, where net income nearly doubles and ROA approximates a doubling as well, which may point to notable events, strategic initiatives, or market conditions influencing financial outcomes in the latest year.